NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,247 Cr | ₹1,189 Cr | ₹856 Cr | ₹621 Cr | ₹413 Cr |
What is the latest Sundry Debtors ratio of NATCO PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹1,247 Cr |
| Mar2024 | ₹1,189 Cr |
| Mar2023 | ₹856 Cr |
| Mar2022 | ₹621 Cr |
| Mar2021 | ₹413 Cr |
How is Sundry Debtors of NATCO PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,247 Cr | 4.85 | |
| Mar2024 | ₹1,189 Cr | 38.87 | |
| Mar2023 | ₹856 Cr | 37.95 | |
| Mar2022 | ₹621 Cr | 50.30 | |
| Mar2021 | ₹413 Cr | - | |
Compare Sundry Debtors of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹17,129.1 Cr | 10.7% | 18.3% | 21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 10.7% |
18.3% |
21.8% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses